Phase 2 Study of Relugolix vs Placebo in Heavy Menstrual Bleeding Associated With Uterine Fibroids

被引：11
|
作者：
Hoshiai, Hiroshi [1 ]
Seki, Yoshifumi [1 ]
Kusumoto, Takeru [1 ]
Kudou, Kentarou [1 ]
Komura, Emiko [1 ]
Tanimoto, Masataka [1 ]
机构：
[1] Kinki Univ, Fac Med, Osaka, Japan
来源：
OBSTETRICS AND GYNECOLOGY | 2017年 / 129卷
关键词：
D O I：
10.1097/01.AOG.0000514919.44544.95
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
17H
引用
收藏
页码：86S / 86S
页数：1
相关论文
共 50 条
  • [31] Endometrial Evaluation in Elagolix-Treated Women With Uterine Fibroids and Heavy Menstrual Bleeding
    Carr, Bruce R.
    Bradley, Linda D.
    Owens, Charlotte D.
    Gao, Jinging
    Chwalisz, Kristof
    Simon, James A.
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 82S - 83S
  • [32] Surgical Treatment of Fibroids in Heavy Menstrual Bleeding
    Saridogan, Ertan
    WOMENS HEALTH, 2016, 12 (01) : 53 - 62
  • [33] State Level Treatment Differences in Heavy Menstrual Bleeding and Uterine Fibroids: Claims Analysis
    Wang, Alice
    Wang, Siting
    Vora, Jamie
    Diamond, Michael
    OBSTETRICS AND GYNECOLOGY, 2020, 135 : 27S - 28S
  • [34] Oriahnn: New Drug Approved for Treating Heavy Menstrual Bleeding in Women With Uterine Fibroids
    Lynch, Sarah E.
    Mayer, Danielle C.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (01) : 93 - 101
  • [35] ELAGOLIX IMPROVES QUALITY OF LIFE IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS: EVIDENCE FROM A PHASE 2B RANDOMIZED TRIAL.
    Diamond, M.
    Soliman, A. M.
    Gao, J.
    Owens, C.
    Chwalisz, K.
    Archer, D. F.
    FERTILITY AND STERILITY, 2017, 108 (03) : E27 - E27
  • [36] MEASURING PATIENT-REPORTED OUTCOMES IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS: THE BLEEDING AND PELVIC DISCOMFORT SCALE.
    Li, Juliet
    Kang, Jennifer B.
    Hunsche, Elke
    Hudgens, Stacie
    FERTILITY AND STERILITY, 2019, 112 (03) : E344 - E344
  • [37] Efficacy and safety of linzagolix on heavy menstrual bleeding (HMB) due to uterine fibroids (UF): Results from a placebo-controlled, randomized, Phase 3 trial
    Taylor, H.
    Donnez, J.
    Taylor, R.
    Bestel, E.
    Gotteland, J. P.
    Humberstone, A.
    Garner, E.
    HUMAN REPRODUCTION, 2020, 35 : 13 - 13
  • [38] Informing Patient Selection for Elagolix Treatment of Heavy Menstrual Bleeding Associated With Fibroids
    Al-Hendy, Ayman
    Simon, James A.
    Bradley, Linda D.
    Owens, Charlotte
    Wang, Hui
    Barnhart, Kurt
    OBSTETRICS AND GYNECOLOGY, 2020, 135 : 24S - 24S
  • [39] The history and use of the progesterone receptor modulator ulipristal acetate for heavy menstrual bleeding with uterine fibroids
    Bouchard, Philippe
    Chabbert-Buffet, Nathalie
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2017, 40 : 105 - 110
  • [40] Efficacy and Safety of Elagolix 150 mg QD in Women With Uterine Fibroids and Heavy Menstrual Bleeding
    Kroll, Robin
    Poindexter, Alfred
    Ng, Juki
    Li, Hong
    Snabes, Michael
    OBSTETRICS AND GYNECOLOGY, 2022, 139 : 26S - 26S
12345